Medicine and Dentistry
Patient
100%
Maturity Onset Diabetes of the Young
92%
Inpatient
70%
Diagnosis
55%
Serum
54%
Woman
50%
Patient with Type 2 Diabetes
48%
Glucose
44%
Primary Hyperaldosteronism
40%
Diabetes Mellitus
40%
Cells
33%
Association
32%
Diabetes
29%
Gemigliptin
29%
Glycon
29%
Cohort Analysis
29%
Cushing Syndrome
28%
Plasma
27%
Glucose Tolerance
27%
Surgery
23%
Health
22%
Hemoglobin A1c
22%
Promoter Region
22%
Papillary Thyroid Cancer
22%
Endotoxemia
21%
Congenital Adrenal Hyperplasia
21%
Muscle
21%
Examination
21%
Retrospective Cohort Study
21%
Cell Function
21%
Hyperglycemia
20%
Incretin
20%
Physician
19%
Gestational Diabetes
19%
Position
19%
Dipeptidyl Peptidase-4 Inhibitor
19%
Amlodipine
19%
Glomerular Filtration Rate
19%
Computer-Aided Diagnosis
19%
Thyroid Nodule
19%
Creatinine
19%
Glycation
19%
Pheochromocytoma
19%
Paraganglioma
19%
Insulin
19%
Glucagon Like Peptide 1
17%
Analysis
17%
Glucagon-Like Peptide-1 Agonist
17%
Impaired Glucose Tolerance
16%
Incidence
15%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
58%
Drug
40%
Insulin
38%
Glucose
33%
Antidiabetic Agent
30%
Gemigliptin
29%
Dipeptidyl Peptidase IV Inhibitor
27%
Thiazolidinedione
25%
Hypertension
22%
Glucagon Like Peptide 1 Receptor Agonist
22%
Hemoglobin A1c
20%
Congenital Adrenal Hyperplasia
19%
Steroid 21 Monooxygenase Deficiency
19%
Primary Hyperaldosteronism
19%
Insulinoma
19%
Amlodipine
19%
Endotoxemia
19%
Corticotropin
17%
Cushing Syndrome
17%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Cardiovascular Disease
14%
Steroids
13%
Antilipemic Agent
12%
Subtilisin
12%
Sulfonylurea
11%
Incidence
11%
Androgen
11%
Blindness
10%
Prasterone
10%
Placebo-Controlled Study
9%
Apolipoprotein B
9%
Hemoglobin
9%
Metformin
9%
Mineral
9%
Angiotensin
9%
Adrenal Tumor
9%
Hypothyroidism
9%
Dyslipidemia
9%
Statin (Protein)
9%
Fat
9%
Fimasartan
9%
Observational Study
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Familial Hypercholesterolemia
9%
Olmesartan
9%
Cushing Disease
9%
Lipid
9%
Nonfunctioning Pituitary Adenoma
9%
Thyroid Carcinoma
9%
Cohort Study
9%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
32%
Glucose
30%
Glucose Tolerance
22%
Insulin
22%
Incretin
20%
Steroid 21 Monooxygenase Deficiency
19%
Congenital Adrenal Hyperplasia
19%
Algorithm
19%
Gemigliptin
19%
Endotoxemia
19%
Glycation
19%
Glucose Level
13%
Glucose Blood Level
13%
Parameters
11%
Impaired Glucose Tolerance
11%
Diabetes Mellitus
11%
Glucagon Like Peptide 1
11%
Prediction
10%
Cardiovascular Disease
10%
Hemoglobin A1c
10%
Body Composition
10%
Dipeptidyl Peptidase IV Inhibitor
9%
Heart Rate
9%
Laboratory
9%
Fimasartan
9%
Amlodipine
9%
Primary Hyperaldosteronism
9%
Cohort Analysis
9%
Evaluation Study
9%
Hemoglobin
9%
Hypothyroidism
9%
Fiber
9%
Fat
9%
Androgen
9%
Bone Density
9%
Lipid
9%
Titrimetry
9%
Insulin Glargine
9%
Sodium Glucose Cotransporter 2
9%
Devices
9%
Thyroid Carcinoma
9%
Primary Hyperaldosteronism
9%
Pheochromocytoma
9%
Paraganglioma
9%
Biochemical Marker
9%
Hyperglycemia
9%
Dapagliflozin
8%
Area under the Curve
7%
American Shoulder and Elbow Surgeons Score
7%
Gastric Inhibitory Polypeptide
6%
